Abstract:OBJECTIVE:Vectors commonly used for therapeutic angiogenesis such as adenovirus and plasmid had their own limitations. Adenovirus-associated virus (AAV) is a relatively new but probably more ideal vector as it is safe and efficient. We will study the efficiency of recombinant AAV-2 mediated vascular endothelial growth factor165 gene transfer in inducing angiogenesis and arteriogenesis, in improving blood flow and myocardium function in a porcine chronic myocardial ischemic model.METHODS:Chinese experimental minipigs underwent placement of a left circumflex artery aneroid constrictor. Five weeks later, electrocardiogram, coronary angiography and magnetic resonance imaging were performed to confirm occlusion of LCX or ischemia of myocardium in LCX territory. Coronary blood flow, myocardium perfusion and left ventricular wall function were also evaluated. Then the animals were randomized to treatment with rAAV2-VEGF(165) (1 x 10(12) virus genome) or administration of PBS, both by direct myocardial injection. Three and six months after therapy, the animals were evaluated with regard to expression of VEGF(165) Capillary density and arteriole density of the ischemic myocardium, coronary angiography, myocardial perfusion and left ventricular function were also assessed six months after therapy.RESULTS:Five weeks after aneroid occluder implantation, all the animals demonstrated complete or nearly complete occlusion of LCX and perfusion deficiency in LCX territory. Three months after therapy, expression of VEGF(165) mRNA and protein were higher in the VEGF than control group. The difference between the two groups diminished after six months. There was significant increase in capillary density (1404.06 +/- 250.48/mm(2) vs 976.88 +/- 344.79/mm(2), P < 0.05) and arteriole density (167.81 +/- 36.29/mm(2) vs 116.56 +/- 34.48/mm(2), P < 0.05) in VEGF group compared with control. Comparison of myocardial perfusion demonstrated marked differences between the two groups with significant improvement in animals treated with rAAV2-VEGF(165). No significant improvement in left ventricular function was seen in either the VEGF or control group.CONCLUSIONS:Transmyocardial delivery of rAAV2-VEGF(165) resulted in VEGF gene expression for at least three months and stimulated angiogenesis and arteriogenesis in porcine model of chronic myocardial ischemia. Myocardial perfusion was also improved after VEGF gene delivery.

"Molecular Bypass": The Application of vascular endothelial growth factor to gene therapy of experimental limb ischemia

[Expression of Human VEGF165 Gene in Rat Bone Marrow Stromal Cells in Vitro].

Vascular Regeneration in Ischemic Hindlimb by Adeno‐Associated Virus Expressing Conditionally Silenced Vascular Endothelial Growth Factor

Optimization of Adenovirus-Mediated Endothelial Nitric Oxide Synthase Delivery in Rat Hindlimb Ischemia

Gene therapy by virus-like self-spooling toroidal DNA condensates for revascularization of hindlimb ischemia

Augmentation of Revascularization and Prevention of Plasma Leakage by Angiopoietin-1 and Vascular Endothelial Growth Factor Co-Transfection in Rats with Experimental Limb Ischaemia

Cell-mediated Delivery of VEGF Modified Mrna Enhances Blood Vessel Regeneration and Ameliorates Murine Critical Limb Ischemia.

Combination of Angiopoietin-1 and Vascular Endothelial Growth Factor at Proper Ratio Promoted Functional Neovascularization in Rats with Experimental Limb Ischemia

Effects of Combined Angiopoietin-1 and Vascular Endothelial Growth Factor Gene Transfer on Neovascular Permeability of Rat Hindlimb Ischemia

Intravascular Magnetic Resonance/radiofrequency May Enhance Gene Therapy for Prevention of In-Stent Neointimal Hyperplasia.

Direct Gene Transfer of Naked DNA Encoding Vascular Endothelial Growth Factor into Ischemic Rat Myocardium

Vascular Endothelial Grow Factor 165 and Angiopoitin-1 Augment Revascularization in a Rat Hindlimb Ischemia Model

[The in Vivo and in Vitro Effects on Neovascularization of VEGF Gene Transfer with a New Pseudotyped Raav1 Vector].

Transplantation Of Novel Vascular Endothelial Growth Factor Gene Delivery System Manipulated Skeletal Myoblasts Promote Myocardial Repair

The Combined Delivery of the Vegf, Ang, and Gdnf Genes Stimulates Angiogenesis and Improves Post-Ischemic Innervation and Regeneration in Skeletal Muscle

[Application of Polytetrafluoroethylene As VEGF Gene Carrier].

Cell-modified Bioprinted Microspheres for Vascular Regeneration

VEGFR endocytosis regulates the angiogenesis in a mouse model of hindlimb ischemia

Intramuscular electroporation of angiopoietin-1 gene augments revascularization in the rat ischemic hindlimb

Raav-Mediated VEGF Gene Transfer Induces Neovascular Formation in a Rabbit Myocardial Ischemic Model

Recombinant Adeno-Associated Viral Vector 2-Mediated Gene Transfer of VEGF165 Improved Porcine Chronic Myocardial Ischemia